Welcome guest, Sign in

Home

X
加载中

Multidrug resistance Acinetobacter baumannii (A. baumannii) (MDRAB) has emerged as a serious threat in hospitals in recent years. Currently, there are few antibiotics, including tigecycline, available to treat infections caused by MDRAB effectively. Both tigecycline-resistant and tigecycline-susceptible isogenic strains of MDRAB are valuable in understanding the mechanisms underlying tigecycline resistance. To get the isogenic strains in the laboratory, we describe a protocol for induction of tigecycline resistance in A. buamannii by serial passage to plates with tigecycline of different concentrations. The minimal inhibitory concentration of A. baumannii by tigecycline was determined according to the protocol “Minimal Inhibitory Concentration (MIC) Assay for Acinetobacter baumannii” (Lin et al., 2014b).

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Induction of Tigecycline Resistance in Acinetobacter baumannii

Microbiology > Antimicrobial assay > Antibacterial assay
Authors: Ming-Feng Lin
Ming-Feng LinAffiliation 1: Department of Medicine, National Taiwan University Hospital Chu-Tung Branch, Taiwan
Affiliation 2: Institute of Molecular and Cellular Biology, National Tsing Hua University, Taiwan
Bio-protocol author page: a1836
Yun-You Lin
Yun-You LinAffiliation: Institute of Molecular and Cellular Biology, National Tsing Hua University, Taiwan
Bio-protocol author page: a1837
 and Chung-Yu Lan
Chung-Yu LanAffiliation: Institute of Molecular and Cellular Biology, National Tsing Hua University, Taiwan
For correspondence: cylan@life.nthu.edu.tw
Bio-protocol author page: a1838
Vol 4, Iss 23, 12/5/2014, 1848 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1307

[Abstract] Multidrug resistance Acinetobacter baumannii (A. baumannii) (MDRAB) has emerged as a serious threat in hospitals in recent years. Currently, there are few antibiotics, including tigecycline, available to treat infections caused by MDRAB effectively. Both tigecycline-resistant and tigecycline-susceptible isogenic strains of MDRAB are valuable in understanding the mechanisms underlying tigecycline resistance. To get the isogenic strains in the laboratory, we describe a protocol for induction of tigecycline resistance in A. buamannii by serial passage to plates with tigecycline of different concentrations. The minimal inhibitory concentration of A. baumannii by tigecycline was determined according to the protocol “Minimal Inhibitory Concentration (MIC) Assay for Acinetobacter baumannii” (Lin et al., 2014b).

Keywords: Acinetobacter baumannii, Tigecycline, Drug resistance, Serial passages

Materials and Reagents

  1. A. baumannii (ATCC, catalog number: 17978)
  2. Tigecycline (Wyeth, catalog number. 0220620-09-7)
  3. Tryptone (Pronadisa, catalog number: 1612)
  4. Yeast extract (Pronadisa, catalog number: 1702)
  5. NaCl (MDBio, catalog number: 101-1647-14-5)
  6. 99% glycerol (Honeywell International, Riedel-deHaen, catalog number: 5523)
  7. Lysogeny broth (LB) (see Recipes)
  8. 20% glycerol (see Recipes)

Equipment

  1. 50 ml polystyrene culture tubes (sterile)
  2. 37 °C shaking and static incubators
  3. Multichannel pipette (volume ranges 10 μl-1,000 μl)

Procedure

  1. Fetch the A. baumannii ATCC 17978 stock stored at -80 °C, scrape the surface of the frozen stock, and plate it on a LB agar.
  2. Put the LB agar in the 37 °C incubator overnight.
  3. Dissolve a single colony of A. baumannii from the overnight culture in 3 ml LB broth and incubate overnight at 37 °C, 220 rpm.
  4. On day 1, 3 ml of LB broth containing tigecycline at the MIC, which is determined by the protocol “Minimal Inhibitory Concentration (MIC) Assay for Acinetobacter baumannii” (Lin et al., 2014b), is inoculated with 30 μl broth containing A. baumannii (step 1), and the cultures are incubated at 37 °C with shaking (220 rpm) overnight.
    Note: The choice of the volumes 30 μl and 3 ml is aimed to keep 1:100 dilutions. If other volumes or dilution ratios are used, it may lead to the change of tigecycline resistance induction time.
  5. On day 3, 30 μl of the culture is transferred to 3 ml of LB broth containing tigecycline at 8x MIC (step 2), and the cultures are again incubated at 37 °C with shaking (220 rpm). If no bacterial growth is noted from step 1, lower the tigecycline concentration to half of the 8x MIC, then repeat step 1.
  6. On day 5, 30 μl of the culture is transferred into LB broth containing tigecycline at 16x MIC (step 3), and the cultures are again incubated at 37 °C with shaking (220 rpm).
  7. This passaging is repeated on day 7 (step 4).
  8. On day 9, aliquots (0.5 ml) of the cultures are mixed with 0.5 ml 20% glycerol and stored at -80 °C until use.
  9. Daily passaging in tigecycline-free LB is conducted for 30 days after the tigecycline resistant strain is obtained to make sure the induction of tigecycline resistance is successful and long-lasting.

Recipes

  1. LB
    10 g tryptone
    5 g yeast extract
    5 g NaCl
    Fill to 1 L with ddH2O
    Sterilized by autoclaving at 121 °C for 15 min
  2. 20% glycerol
    20 ml 99% glycerol fill to 100 ml with ddH2O
    Sterilized by autoclaving at 121 °C for 15 min

Acknowledgments

The development of this protocol was funded by a grant from the National Taiwan University Hospital, Chu-Tung Branch.

References

  1. Lin, M. F., Lin, Y. Y., Yeh, H. W. and Lan, C. Y. (2014a). Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility. BMC Microbiol 14: 119.
  2. Lin, M., Lin, Y. and Lan, C. (2014b). Minimal inhibitory concentration (MIC) assay for Acinetobacter baumannii. Bio-protocol 4(23): e1308.


How to cite this protocol: Lin, M., Lin, Y. and Lan, C. (2014). Induction of Tigecycline Resistance in Acinetobacter baumannii. Bio-protocol 4(23): e1307. DOI: 10.21769/BioProtoc.1307; Full Text



Share Your Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook